| Officer | Age | In this role | Joined | 2025 pay | Source |
|---|---|---|---|---|---|
|
David Pacitti
Also a director
Chief Executive Officer and Board Member
|
59 | Not stated | Not stated | $9,469,803 | |
|
Scott Galovan
Also a director
Senior Vice President, Chief Financial Officer
|
47 |
Since 2025
1 year
|
2013 | $2,039,138 | |
|
John S. Fischer
Also a director
General Counsel and Secretary
|
Not stated | Not stated | Not stated | Not reported | |
|
Sigfrido Delgado
Senior Vice President, Operations
|
49 |
Since 2024
2 years
|
2024 | $1,722,819 | |
|
John Joseph Hurley
Principal Accounting Officer
Title from the Form 4 dated Mar 13, 2026
|
Not stated | Not stated | Not stated | Not reported |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
From the proxy statement filed Mar 12, 2026 · updated by the 8-K of Jul 30, 2026
| Director | Age | On board | Independent | Other public boards | Pay | Source |
|---|---|---|---|---|---|---|
|
David C. Pacitti
CEO
|
59 |
2025
1 year
|
Not independent | Orchestra BioMed Holdings, Inc. (NASDAQ: OBIO) | Paid as CEO | |
|
Scott M. Galovan
Joined Jul 30, 2026
|
- | - | - | - | - | |
|
John S. Fischer
Joined Jul 30, 2026
|
- | - | - | - | - |
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.
The proxy filed Mar 12, 2026 states there were none.
Read it in the proxyLoading...